The Toronto Drug Strategy (TDS) is a comprehensive drug strategy for the City of Toronto based on four integrated parts – prevention, harm reduction, treatment and enforcement. All four parts are needed to effectively reduce the harms of alcohol and other drug use.

The current focus of the Toronto Drug Strategy is the implementation of the Toronto Overdose Action Plan, which provides a comprehensive set of actions to prevent and respond to overdoses. The Plan combines the knowledge and expertise of people who use drugs, their family and friends, and people working in the field with best practices.

Toronto Public Health worked with community partners to develop the Toronto Overdose Action Plan: Prevention & Response, which was endorsed by the Board of Health on March 20, 2017. This includes a comprehensive set of actions for all orders of government to prevent and respond to drug overdoses:

The Toronto Overdose Action Plan was updated in 2019 based on broad community input. This update, which is a supplement to the original Toronto Overdose Action Plan, was endorsed by the Board of Health and City Council in June 2019:

In June 2020, the Toronto Board of Health approved the Toronto Overdose Action Plan: Status Update 2020.

On February 25, 2019, the Board of Health endorsed the Toronto Indigenous Overdose Strategy (TIOS). This strategy was developed by an Indigenous facilitator and is grounded in the input of Indigenous People who use/used drugs, and service providers that work with Indigenous People who use drugs. The recommendations reflect key actions needed in the areas of prevention, harm reduction and treatment. Toronto Public Health (TPH) is supporting implementation of the strategy, and will undertake the actions directed to TPH. Toronto Public Health will also support implementation of the TIOS in collaboration with Indigenous service providers and community members, including Indigenous People who use/have used substances, and other City divisions.

Toronto Public Health conducted a community dialogue process to explore how we can change our approach to drugs and what a public health approach to drugs could look like for Canada.